<SEC-DOCUMENT>0001140361-23-058659-index.html : 20231220 <SEC-HEADER>0001140361-23-058659.hdr.sgml : 20231220 <ACCEPTANCE-DATETIME>20231220163115 ACCESSION NUMBER: 0001140361-23-058659 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231214 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 231501680 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>ef20017039_8ka.htm <DESCRIPTION>8-K/A <TEXT> Document 1 - file: ef20017039_8ka.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ef20017039_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: ef20017039_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>3 <FILENAME>roiv-20231214.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA <TEXT> Document 3 - file: roiv-20231214.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>4 <FILENAME>roiv-20231214_lab.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE <TEXT> Document 4 - file: roiv-20231214_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>5 <FILENAME>roiv-20231214_pre.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE <TEXT> Document 5 - file: roiv-20231214_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>6 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 6 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>7 <FILENAME>ef20017039_8ka_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 7 - file: ef20017039_8ka_htm.html
Document 7 - RAW XML: ef20017039_8ka_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>8 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: FilingSummary.html
Document 11 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>13 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>14 <FILENAME>0001140361-23-058659-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: 0001140361-23-058659-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>